Fortress Biotech (FBIO)
NASDAQ:FBIO
Holding FBIO?
Track your performance easily

Fortress Biotech (FBIO) Financial Statements

1,261 Followers

Fortress Biotech Financial Overview

Fortress Biotech's market cap is currently ―. The company's EPS TTM is $-16.618; its P/E ratio is -0.12; Fortress Biotech is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-1.21. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 14.90M$ 13.03M$ 34.75M$ 17.39M$ 12.43M
Gross Profit$ 8.36M$ 6.21M$ 28.32M$ 9.19M$ -6.23M
EBIT$ -24.69M$ -33.82M$ -8.71M$ -41.46M$ -62.76M
EBITDA$ -21.36M$ -31.47M$ -5.95M$ -37.94M$ -59.72M
Net Income Common Stockholders$ -13.34M$ -17.73M$ -7.05M$ -26.78M$ -21.54M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 76.20M$ 83.77M$ 72.31M$ 86.77M$ 152.48M
Total Assets$ 145.69M$ 164.65M$ 150.55M$ 180.45M$ 263.55M
Total Debt$ 85.42M$ 81.64M$ 67.15M$ 67.16M$ 116.54M
Net Debt$ 9.22M$ -2.13M$ -5.16M$ -19.61M$ -35.95M
Total Liabilities$ 160.28M$ 168.58M$ 163.79M$ 196.66M$ 243.75M
Stockholders Equity$ 17.88M$ 23.02M$ 16.67M$ 18.51M$ 37.80M
Cash Flow-
Free Cash Flow$ -21.84M$ -25.39M$ -10.80M$ -38.26M$ -43.26M
Operating Cash Flow$ -21.84M$ -25.39M$ -16.80M$ -33.22M$ -43.26M
Investing Cash Flow--$ 5.00M$ -2.04M$ -5.00M
Financing Cash Flow$ 14.27M$ 27.86M$ -2.69M$ -30.38M$ 22.19M
Currency in USD

Fortress Biotech Earnings and Revenue History

Fortress Biotech Debt to Assets

Fortress Biotech Cash Flow

Fortress Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis